Platelet-Related Biomarkers and Their Response to Inhibition with Aspirin and P2Y(12)-Receptor Antagonists in Patients with Acute Coronary Syndrome

BACKGROUND: The PLATelet inhibition and patient Outcomes (PLATO) trial showed that treatment with ticagrelor reduced the rate of death due to vascular causes, myocardial infarction and stroke when compared to clopidogrel in patients with ST-elevation or non-ST-elevation acute coronary syndrome (ACS)...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Thromb Thrombolysis
Autori principali: Lowenstern, Angela, Storey, Robert F, Neely, Megan, Sun, Jie-Lena, Angiolillo, Dominick J, Cannon, Christopher P, Himmelmann, Anders, Huber, Kurt, James, Stefan K, Katus, Hugo A, Morais, Joao, Siegbahn, Agneta, Steg, Phillippe Gabriel, Wallentin, Lars, Becker, Richard C
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2017
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6744836/
https://ncbi.nlm.nih.gov/pubmed/28608165
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11239-017-1516-y
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi